If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Tobacco firm Philip Morris seals deal for UK's Vectura with 75% support

Thu, 16th Sep 2021 07:33

* Holders of roughly 75% Vectura shares tender support

* PMI needed 50% backing for deal to go through

* Extends deadline for other holders to tender shares by
Sept. 30
(Adds detail, background)

By Pushkala Aripaka

Sept 16 (Reuters) - Cigarette maker Philip Morris (PMI)
has clinched the roughly 1-billion-pound takeover of
inhaler maker Vectura after winning the backing of about
75% of shareholders in the British company, part of its
expansion beyond tobacco.

Vectura shareholders had until Sept. 15 to decide whether to
support the 165 pence-per-share bid from PMI, which sought to
buy the London-listed asthma drug maker as part of its plan to
go "smoke-free" and switch to healthcare and wellness products.

"We have reached an important milestone in our acquisition
of Vectura and are pleased to have secured over 74% of the
company's shares, in excess of the 50% required to make our
offer unconditional and PMI the majority shareholder," PMI Chief
Executive Jacek Olczak said in a statement on Thursday.

PMI had received the shares from shareholders through a
public tender offer process, and the cigarette maker's offer for
Vectura cannot be withdrawn now.

PMI, which fought off private equity firm Carlyle Group
for the buyout of Vectura, had switched its proposal to a
takeover offer from a so-called scheme of arrangement to raise
its chances.

The switch allowed PMI to require the support of holders of
just over 50% of Vectura shares for the deal to go through.

Philip Morris has received regulatory clearances for the
deal and had won the backing of Vectura's board, but health
groups are questioning the idea of a tobacco company making
money from treating the very illnesses that cigarettes cause.

Olczak said PMI would provide Vectura's scientists with the
resources and expertise to reach a target of at least $1 billion
in net revenue from its "Beyond Nicotine" products by 2025.

The U.S.-based company has also extended the deadline for
the remaining Vectura shareholders to tender their shares to
Sept. 30.

($1 = 0.7234 pounds)
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Devika
Syamnath and Emelia Sithole-Matarise)

More News
27 May 2020 13:10

UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease

UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease

Read more
1 May 2020 14:30

Vectura upbeat on EMA nod for 'Enerzair Breezhaler'

(Sharecast News) - Inhalation contract manufacturer Vectura Group noted an announcement from Novartis on Friday, that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of 'Enerzair Breezhaler'.

Read more
23 Mar 2020 09:43

UK BROKER RATINGS SUMMARY: Barclays Raises Pearson, Moneysupermarket

UK BROKER RATINGS SUMMARY: Barclays Raises Pearson, Moneysupermarket

Read more
17 Mar 2020 12:31

Vectura Resilient Against Covid-19 As Flutiform Drives Annual Growth

Vectura Resilient Against Covid-19 As Flutiform Drives Annual Growth

Read more
10 Mar 2020 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
27 Jan 2020 09:36

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC

Read more
21 Jan 2020 12:48

Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director

Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director

Read more
13 Jan 2020 09:19

Vectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On

Vectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On

Read more
13 Jan 2020 08:25

Vectura sees FY revenues and earnings 'at least' in line with expectations

(Sharecast News) - Pharmaceuticals company Vectura said on Monday that its base business had continued to perform well in 2019.

Read more
27 Nov 2019 08:26

TOP NEWS: Hikma Submits Response To Advair Application Deficiencies

TOP NEWS: Hikma Submits Response To Advair Application Deficiencies

Read more
29 Oct 2019 09:41

Vectura Group Hires Former GE Healthcare Exec Will Downie As New CEO

Vectura Group Hires Former GE Healthcare Exec Will Downie As New CEO

Read more
18 Oct 2019 16:06

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
4 Oct 2019 17:31

UPDATE 1-Vectura, Sandoz win ruling on inhaler packaging case against GSK

(Adds comment from GSK spokesman)Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its favour on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.Vectura said the court dismissed all G...

Read more
4 Oct 2019 14:24

High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler

High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler

Read more
3 Oct 2019 16:04

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.